Novo Pays PE Firm $708M For Stake In Chr. Hansen
Novo A/S, the parent of diabetes care company Novo Nordisk A/S, is buying 35.4 million shares of Chr. Hansen Holding A/S for $708 million from private equity firm PAI Partners SAS,...To view the full article, register now.
Already a subscriber? Click here to view full article